We address some of the toughest challenges in brain health—areas where subjective assessment demands objective precision. Leveraging advanced neuroimaging, we bridge the gap from groundbreaking research to regulatory-ready solutions, developing biomarkers where conventional diagnostics fall short. Mayamind® is leading the way in dementia subtyping, with ongoing efforts expanding into depression and sleep medicine.
We operate at the intersection of academia, healthcare, and technology. Our projects are supported by competitive grants across the globe.
We actively collaborate with hospitals, research institutes, and regulatory experts across Japan, India, and the US to bring innovation from the lab to the clinic.
Redefining brain health starts here. Be part of the innovation.
Bold Science. Steady Minds.
Mental healthcare lags behind modern medicine, relying on subjective assessments. Insanity Labs is driving change with innovative research and technologies.
We build precision medical technologies for mental health disorders.
Where cutting-edge science meets clinical excellence to transform lives.
